Gujarat Terce Laboratories Ltd
₹34.13
-2.78 (7.53%)
Sun, 25 Oct 2026, 07:58 pm
Health Technology
Pharmaceuticals: Major
24.5KGujarat Terce Laboratories Share Price Live Chart
1 Day
-2.78 (7.53%)
No Result Found
Summary
Market Cap (in Cr)
26.59
Net Profit (in Cr)
2.2
P/B
2.47
Sector P/E
47.36
P/E
10.92
EV/EBITDA
6.20
Debt/Equity (Industry)
0.33
Interest Cover (Industry)
13.04
ROCE (Industry)
14.50
RONW (Industry)
13.64
ROE
28.46
ROCE
27.03
Debt/Equity
0.14
EPS (TTM)
2.86
Dividend Yield
0
Book Value
12.49
Interest Cover
20.06
Analysis
all
- Gujarat Terce Laboratories is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Gujarat Terce Laboratories is profitable, therefore cash runway is not a concern.
- Gujarat Terce Laboratories is profitable, therefore cash runway is not a concern.
- Debt is covered by short term assets, assets are 5.5x debt.
- Gujarat Terce Laboratories's cash and other short term assets cover its long term commitments.
- Unable to evaluate Gujarat Terce Laboratories's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Gujarat Terce Laboratories's dividend against the top 25% market benchmark as the company has not reported any payouts.
- Operating cash flow is negative therefore debt is not well covered.
- High level of physical assets or inventory.
- The average tenure for the Gujarat Terce Laboratories management team is less than 2 years, this suggests a new team.
Shareholding
| Shareholders | SEPT 2026 | JUN 2026 | MAR 2026 | DEC 2025 | SEPT 2025 |
|---|---|---|---|---|---|
| Promoters | 40.03 | 40.03 | 40.03 | 40.03 | 37.03 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 |
| Public | 59.97 | 59.97 | 59.97 | 59.97 | 62.97 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 51.51 | 44.66 | 40.38 | 37.81 | 33.53 | 30.96 | 24.11 |
| Fibonacci | 44.66 | 42.05 | 40.43 | 37.81 | 35.20 | 33.58 | 30.96 |
| Camarilla | 37.97 | 37.35 | 36.72 | 37.81 | 35.46 | 34.83 | 34.21 |
Pivots Level: Classic
R3
+13.70
51.51
R2
+6.85
44.66
R1
+2.56
40.38
S1
-4.29
33.53
S2
-6.85
30.96
S3
-13.70
24.11
Moving Average
Period
Value
10-EMA
36.63
20-EMA
37.27
30-EMA
37.55
50-EMA
37.67
100-EMA
37.66
200-EMA
39.29
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 01 Jun 2026 | agm | ||
| 29 May 2026 | board-meetings | Accounts, Quarterly Results, AGM | |
| 27 May 2026 | board-meetings | Accounts, AGM | |
| 04 Feb 2026 | board-meetings | Quarterly Results | |
| 08 Nov 2025 | board-meetings | Quarterly Results | |
| 17 Jul 2025 | agm | ||
| 09 Aug 2024 | agm | ||
| 29 Mar 2024 | egm | ||
| 07 Jun 2023 | agm | ||
| 31 May 2022 | agm |
Peer Comparison
Gujarat Terce Laboratories Ltd
Divis Laboratories Ltd
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Zydus Lifesciences Ltd
Gujarat Terce Laboratories Ltd About
Gujarat Terce Laboratories is an Indian public pharmaceutical company It specializes in the manufacturing, marketing, and distribution of branded generics, pharmaceutical formulations, and medical preparations across 13 Indian states.
Industry
Pharmaceuticals - Indian - Formulations
Founded
1985
Headquarters
CEO
Natwarbhai P Prajapati
Employees
Contact
Website
http://www.gtll.in; www.gujaratterce.com
ho@gujaratterce.com
Phone
91-079-6663 3706
Location
122/2 Ravi Estate, Bileshwarpura Chhatral, Gandhinagar, Gujarat, 382729
Gujarat Terce Laboratories Ltd Company History
| Year | History |
|---|---|
| 1985 |
|
| 1992 |
|
| 2019 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| NELVIN GEORGE | bulk | Sell | 40212 | 51.37 | 26 Jun 2025 |
| MABLE RAJESH | bulk | Buy | 73000 | 52.4 | 15 Apr 2024 |
| DHANPAT M KOTHARI | bulk | Buy | 44772 | 24.92 | 17 Nov 2023 |
| RISHABH NEGI | bulk | Buy | 75000 | 18.6 | 15 Nov 2022 |
| GUPTA | bulk | Sell | 43893 | 20.78 | 25 Aug 2022 |
| RADHIKA RASTOGI | bulk | Sell | 71782 | 32.92 | 16 Jun 2022 |
| RADHIKA RASTOGI | bulk | Buy | 11 | 33.25 | 16 Jun 2022 |
| SATYA PRAKASH MITTAL HUF | bulk | Sell | 119846 | 34.1 | 15 Jun 2022 |
| SATYA PRAKASH MITTAL HUF | bulk | Sell | 44699 | 42.21 | 03 Jun 2022 |
| SATYA PRAKASH MITTAL HUF | bulk | Buy | 1286 | 40.9 | 03 Jun 2022 |
Frequently Asked Questions
1.What is the stock price of Gujarat Terce Laboratories Ltd?
As of 26/10/2026 at 1:28 AM, Gujarat Terce Laboratories Ltd shares are trading at ₹34.13.
2.What is the market cap. of Gujarat Terce Laboratories Ltd?
As of 26/10/2026, the market capitalization of Gujarat Terce Laboratories Ltd is ₹26.59 crore.
3.When was Gujarat Terce Laboratories Ltd founded?
Gujarat Terce Laboratories Ltd was founded in 1985.
4.What are the P/E and P/B ratios of Gujarat Terce Laboratories Ltd?
As of 26/10/2026, Gujarat Terce Laboratories Ltd has a P/E ratio of 12.75 and a P/B ratio of 2.47.
5.How can I buy shares of Gujarat Terce Laboratories Ltd?
You can buy shares of Gujarat Terce Laboratories Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.Does Gujarat Terce Laboratories Ltd pay dividends?
No, Gujarat Terce Laboratories Ltd does not pay dividends to eligible shareholders currently.
7.What are the latest financial results of Gujarat Terce Laboratories Ltd?
For the financial year ended March 2025, Gujarat Terce Laboratories Ltd reported revenue of ₹50.20 crore and a net profit of ₹-0.98 crore.
8.Who is the CEO of Gujarat Terce Laboratories Ltd?
The CEO of Gujarat Terce Laboratories Ltd is Natwarbhai P Prajapati.
